271 related articles for article (PubMed ID: 20140240)
1. Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease.
Morgan NV; Morris MR; Cangul H; Gleeson D; Straatman-Iwanowska A; Davies N; Keenan S; Pasha S; Rahman F; Gentle D; Vreeswijk MP; Devilee P; Knowles MA; Ceylaner S; Trembath RC; Dalence C; Kismet E; Köseoğlu V; Rossbach HC; Gissen P; Tannahill D; Maher ER
PLoS Genet; 2010 Feb; 6(2):e1000833. PubMed ID: 20140240
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic intrafamilial variability including H syndrome and Rosai-Dorfman disease associated with the same c.1088G > A mutation in the SLC29A3 gene.
Chouk H; Ben Rejeb M; Boussofara L; Elmabrouk H; Ghariani N; Sriha B; Saad A; H'Mida D; Denguezli M
Hum Genomics; 2021 Oct; 15(1):63. PubMed ID: 34657628
[TBL] [Abstract][Full Text] [Related]
3. A case of H syndrome showing immunophenotye similarities to Rosai-Dorfman disease.
Avitan-Hersh E; Mandel H; Indelman M; Bar-Joseph G; Zlotogorski A; Bergman R
Am J Dermatopathol; 2011 Feb; 33(1):47-51. PubMed ID: 21178579
[TBL] [Abstract][Full Text] [Related]
4. An Egyptian family with H syndrome due to a novel mutation in SLC29A3 illustrating overlapping features with pigmented hypertrichotic dermatosis with insulin-dependent diabetes and Faisalabad histiocytosis.
Elbarbary NS; Tjora E; Molnes J; Lie BA; Habib MA; Salem MA; Njølstad PR
Pediatr Diabetes; 2013 Sep; 14(6):466-72. PubMed ID: 22989030
[TBL] [Abstract][Full Text] [Related]
5. Emperipolesis: an additional common histopathologic finding in H syndrome and Rosai-Dorfman disease.
Colmenero I; Molho-Pessach V; Torrelo A; Zlotogorski A; Requena L
Am J Dermatopathol; 2012 May; 34(3):315-20. PubMed ID: 22356918
[TBL] [Abstract][Full Text] [Related]
6. Equilibrative nucleotide transporter ENT3 (SLC29A3): A unique transporter for inherited disorders and cancers.
Ma H; Qu J; Liao Y; Liu L; Yan M; Wei Y; Xu W; Luo J; Dai Y; Pang Z; Qu Q
Exp Cell Res; 2024 Jan; 434(2):113892. PubMed ID: 38104646
[TBL] [Abstract][Full Text] [Related]
7. Progressive hearing loss associated with a unique cervical node due to a homozygous SLC29A3 mutation: a very mild phenotype.
Jonard L; Couloigner V; Pierrot S; Louha M; Gherbi S; Denoyelle F; Marlin S
Eur J Med Genet; 2012 Jan; 55(1):56-8. PubMed ID: 21888995
[TBL] [Abstract][Full Text] [Related]
8. SLC29A3 mutation in a patient with syndromic diabetes with features of pigmented hypertrichotic dermatosis with insulin-dependent diabetes, H syndrome and Faisalabad histiocytosis.
de Jesus J; Imane Z; Senée V; Romero S; Guillausseau PJ; Balafrej A; Julier C
Diabetes Metab; 2013 May; 39(3):281-5. PubMed ID: 23623699
[TBL] [Abstract][Full Text] [Related]
9. H syndrome: the first 79 patients.
Molho-Pessach V; Ramot Y; Camille F; Doviner V; Babay S; Luis SJ; Broshtilova V; Zlotogorski A
J Am Acad Dermatol; 2014 Jan; 70(1):80-8. PubMed ID: 24172204
[TBL] [Abstract][Full Text] [Related]
10. Identification of two novel mutations in SLC29A3 encoding an equilibrative nucleoside transporter (hENT3) in two distinct Syrian families with H syndrome: expression studies of SLC29A3 (hENT3) in human skin.
Farooq M; Moustafa RM; Fujimoto A; Fujikawa H; Abbas O; Kibbi AG; Kurban M; Shimomura Y
Dermatology; 2012; 224(3):277-84. PubMed ID: 22653152
[TBL] [Abstract][Full Text] [Related]
11. Human equilibrative nucleoside transporter-3 (hENT3) spectrum disorder mutations impair nucleoside transport, protein localization, and stability.
Kang N; Jun AH; Bhutia YD; Kannan N; Unadkat JD; Govindarajan R
J Biol Chem; 2010 Sep; 285(36):28343-52. PubMed ID: 20595384
[TBL] [Abstract][Full Text] [Related]
12. A mild form of SLC29A3 disorder: a frameshift deletion leads to the paradoxical translation of an otherwise noncoding mRNA splice variant.
Bolze A; Abhyankar A; Grant AV; Patel B; Yadav R; Byun M; Caillez D; Emile JF; Pastor-Anglada M; Abel L; Puel A; Govindarajan R; de Pontual L; Casanova JL
PLoS One; 2012; 7(1):e29708. PubMed ID: 22238637
[TBL] [Abstract][Full Text] [Related]
13. Rosai-Dorfman Disease and Exocrine Pancreatic Insufficiency in a Patient With a Germline SLC29A3 Mutation.
Blatt J; Parekh P; Powell BC; Fedoriw Y; Reddy I; Montgomery ND
J Pediatr Hematol Oncol; 2021 Jul; 43(5):e689-e691. PubMed ID: 32769566
[TBL] [Abstract][Full Text] [Related]
14. Mutation in the SLC29A3 gene: a new cause of a monogenic, autoinflammatory condition.
Melki I; Lambot K; Jonard L; Couloigner V; Quartier P; Neven B; Bader-Meunier B
Pediatrics; 2013 Apr; 131(4):e1308-13. PubMed ID: 23530176
[TBL] [Abstract][Full Text] [Related]
15. Tocilizumab for the Treatment of SLC29A3 Mutation Positive PHID Syndrome.
Rafiq NK; Hussain K; Brogan PA
Pediatrics; 2017 Nov; 140(5):. PubMed ID: 29079714
[TBL] [Abstract][Full Text] [Related]
16. SLC29A3 gene is mutated in pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome and interacts with the insulin signaling pathway.
Cliffe ST; Kramer JM; Hussain K; Robben JH; de Jong EK; de Brouwer AP; Nibbeling E; Kamsteeg EJ; Wong M; Prendiville J; James C; Padidela R; Becknell C; van Bokhoven H; Deen PM; Hennekam RC; Lindeman R; Schenck A; Roscioli T; Buckley MF
Hum Mol Genet; 2009 Jun; 18(12):2257-65. PubMed ID: 19336477
[TBL] [Abstract][Full Text] [Related]
17. A novel 3' untranslated region mutation in the SLC29A3 gene associated with pigmentary hypertrichosis and non-autoimmune insulin-dependent diabetes mellitus syndrome.
Riachi M; Bas F; Darendeliler F; Hussain K
Pediatr Diabetes; 2019 Jun; 20(4):474-481. PubMed ID: 30821020
[TBL] [Abstract][Full Text] [Related]
18. Novel homozygous SLC29A3 mutations among two unrelated Egyptian families with spectral features of H-syndrome.
Al-Haggar M; Salem N; Wahba Y; Ahmad N; Jonard L; Abdel-Hady D; El-Hawary A; El-Sharkawy A; Eid AR; El-Hawary A
Pediatr Diabetes; 2015 Jun; 16(4):305-16. PubMed ID: 24894595
[TBL] [Abstract][Full Text] [Related]
19. Expanding the clinical spectrum of SLC29A3 gene defects.
Spiegel R; Cliffe ST; Buckley MF; Crow YJ; Urquhart J; Horovitz Y; Tenenbaum-Rakover Y; Newman WG; Donnai D; Shalev SA
Eur J Med Genet; 2010; 53(5):309-13. PubMed ID: 20619369
[TBL] [Abstract][Full Text] [Related]
20. Functional outcome of a novel SLC29A3 mutation identified in a patient with H syndrome.
Huber-Ruano I; Errasti-Murugarren E; Godoy V; Vera Á; Andreu AL; Garcia-Arumi E; Martí R; Pastor-Anglada M
Biochem Biophys Res Commun; 2012 Nov; 428(4):532-7. PubMed ID: 23058913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
